Security key
92790C104
Viridian Therapeutics, Inc.\DE - Common Stock (VRDN)
CUSIP: 92790C104
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 101,911,273
- Total 13F shares
- 43,068,809
- Share change
- +1,971,054
- Total reported value
- $1,095,674,908
- Put/Call ratio
- 29%
- Price per share
- $25.44
- Number of holders
- 134
- Value change
- +$43,441,205
- Number of buys
- 81
- Number of sells
- 52
Report period
Q1 2023
Institutions
134
Top holders
10
VRDN full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Viridian Therapeutics, Inc.\DE SEC filings
Viridian Therapeutics, Inc.\DE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92790C104
Recent filing periods:
Top shareholders of VRDN - Viridian Therapeutics, Inc.\DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
2,761,556
|
$80,665,052 | — | 31 Dec 2022 | |
| Venrock Adviser, LLC |
13F
|
Company |
2.6%
|
2,699,865
|
$78,863,057 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
2,114,994
|
$61,778,974 | — | 31 Dec 2022 | |
| Commodore Capital LP |
13F
|
Company |
2%
|
2,020,166
|
$59,009,000 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
1,863,190
|
$54,423,780 | — | 31 Dec 2022 | |
| Deep Track Capital, LP |
13F
|
Company |
1.7%
|
1,771,154
|
$51,735,408 | — | 31 Dec 2022 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
1.7%
|
1,751,167
|
$51,151,588 | — | 31 Dec 2022 | |
| Vivo Capital, LLC |
13F
|
Company |
1.6%
|
1,678,207
|
$49,020,000 | — | 31 Dec 2022 | |
| Fairmount Funds Management LLC |
13F
|
Company |
1.3%
|
1,369,623
|
$40,006,688 | — | 31 Dec 2022 | |
| BVF INC/IL |
13F
|
Company |
1.2%
|
1,238,974
|
$36,190,431 | — | 31 Dec 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
1,220,575
|
$35,652,996 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
1,202,318
|
$35,119,708 | — | 31 Dec 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.1%
|
1,100,000
|
$32,131,000 | — | 31 Dec 2022 | |
| Kynam Capital Management, LP |
13F
|
Company |
1%
|
1,034,697
|
$30,223,499 | — | 31 Dec 2022 | |
| Logos Global Management LP |
13F
|
Company |
0.98%
|
1,000,000
|
$29,210,000 | — | 31 Dec 2022 | |
| TCG Crossover Management, LLC |
13F
|
Company |
0.97%
|
983,610
|
$28,731,248 | — | 31 Dec 2022 | |
| Yiheng Capital Management, L.P. |
13F
|
Company |
0.95%
|
963,256
|
$28,136,708 | — | 31 Dec 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.91%
|
923,833
|
$26,985,162 | — | 31 Dec 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.86%
|
880,000
|
$25,704,800 | — | 31 Dec 2022 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.81%
|
824,200
|
$24,074,882 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.77%
|
785,854
|
$22,955,000 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
710,985
|
$20,767,000 | — | 31 Dec 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.68%
|
692,925
|
$20,240,339 | — | 31 Dec 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.6%
|
611,457
|
$17,860,658 | — | 31 Dec 2022 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.44%
|
444,332
|
$12,978,938 | — | 31 Dec 2022 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
428,273
|
$12,509,854 | — | 31 Dec 2022 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.39%
|
396,500
|
$11,581,765 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
361,689
|
$10,564,936 | — | 31 Dec 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.33%
|
338,167
|
$9,877,858 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.33%
|
335,302
|
$9,794,172 | — | 31 Dec 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.32%
|
324,139
|
$9,468,100 | — | 31 Dec 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.32%
|
321,466
|
$10,920,000 | — | 31 Dec 2022 | |
| BRAIDWELL LP |
13F
|
Company |
0.31%
|
313,403
|
$9,154,502 | — | 31 Dec 2022 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.3%
|
304,552
|
$8,895,964 | — | 31 Dec 2022 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.29%
|
300,000
|
$8,763,000 | — | 31 Dec 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.26%
|
267,765
|
$7,821,000 | — | 31 Dec 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.26%
|
260,091
|
$7,597,258 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.24%
|
243,674
|
$7,117,717 | — | 31 Dec 2022 | |
| Atlas Venture Advisors, Inc. |
13F
|
Company |
0.21%
|
209,505
|
$6,119,641 | — | 31 Dec 2022 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.2%
|
204,600
|
$5,976,366 | — | 31 Dec 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.19%
|
194,537
|
$5,682,425 | — | 31 Dec 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.19%
|
190,654
|
$5,569,000 | — | 31 Dec 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.17%
|
172,359
|
$5,034,000 | — | 31 Dec 2022 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.16%
|
165,000
|
$4,820,000 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
152,553
|
$4,456,073 | — | 31 Dec 2022 | |
| Global IMC LLC |
13F
|
Company |
0.15%
|
151,906
|
$4,437,174 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.14%
|
145,778
|
$4,258,176 | — | 31 Dec 2022 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.14%
|
140,000
|
$4,089,400 | — | 31 Dec 2022 | |
| NORGES BANK |
13F
|
Company |
0.13%
|
134,200
|
$3,919,982 | — | 31 Dec 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.13%
|
131,539
|
$3,842,254 | — | 31 Dec 2022 |
Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) as of Q1 2023
As of 31 Mar 2023,
Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) was held by
134 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,068,809 shares.
The largest 10 holders included
BlackRock Inc., VR Adviser, LLC, STATE STREET CORP, COMMODORE CAPITAL LP, VANGUARD GROUP INC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, and Fairmount Funds Management LLC.
This page lists
134
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
122
Q1 2023 holders
134
Holder diff
12
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.